GA

Garvit Agarwal

Active Director Director DIN 09148949
DIN 09148949 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Garvit Agarwal

Data last updated:

Garvit Agarwal is a Director at Hexa Medical Private Limited (since 2021). The company operates in Healthcare. Hexa Medical Private Limited reported revenue of ₹1.88 Cr (FY 2025).

DIN 09148949
Primary Designation Director
Industry Healthcare
First Appointment 16 Apr 2021
Oldest Company Age 5 yrs
Largest company Hexa Medical Private Limited · ₹1.88 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hexa Medical Private Limited U51909KA2021PTC146617
Director16 Apr 20212021₹1.88 Cr (FY 2025)Active

Board colleagues of Garvit Agarwal

NameDINCompanyDesignation
Sumitra Devi09836613Hexa Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hexa Medical Private Limited
Premium access

Shareholding and investment profile for Garvit Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Garvit Agarwal

Garvit Agarwal currently holds 1 directorship: Hexa Medical Private Limited (Director, since 16 Apr 2021, revenue ₹1.88 Cr (FY 2025)).

Garvit Agarwal was first appointed on 16 Apr 2021 as Director at Hexa Medical Private Limited.

The current boards of Garvit Agarwal's companies include Sumitra Devi (Hexa Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available